Silver Oak Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Silver Oak Advisory Group's LLY Position: Q3 2026 in Review
Silver Oak Advisory Group reduced its Eli Lilly (LLY) stake by 16% in Q3 2026, selling an estimated $73.2K and leaving 332 shares worth $384K. The position accounts for 0.15% of the portfolio, ranked #57.
Silver Oak Advisory Group first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $585K in Q2 2024. 3,734 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Silver Oak Advisory Group held 332 shares of Eli Lilly worth $384K as of Q3 2026.
- Silver Oak Advisory Group sold 62 Eli Lilly shares in Q3 2026, an estimated $73.2K.
- Eli Lilly made up 0.15% of Silver Oak Advisory Group's portfolio in Q3 2026, its #57 holding.
- Silver Oak Advisory Group first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- Silver Oak Advisory Group's Eli Lilly position peaked at $585K in Q2 2024.
- 3,734 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Silver Oak Advisory Group's 13F filing for Q3 2026, filed 6 Nov 2026.